ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of August

August 30, 2013

$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says

October 8, 1993

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

Raising NIH Appropriations Is High Priority, House Subcommittee Chairman Says

March 7, 1997

NCI-Approved Clinical Trials

February 24, 2006

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012